Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents is a research paper published in Diabetes Obesity and Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK021397
NIDDK NIH HHS
Grant: F32 DK127591
NIDDK NIH HHS
Grant: R01 DK021397
Eli Lilly and Company
FWCI
4.92
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals